Should I buy or sell Curaleaf stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Curaleaf in the last year. There are currently 1 sell rating, 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CURLF shares. View CURLF analyst ratings or view top-rated stocks .

What is Curaleaf's stock price target for 2024?

8 Wall Street analysts have issued 12 month price targets for Curaleaf's stock. Their CURLF share price targets range from $4.25 to $32.25. On average, they predict the company's share price to reach $13.00 in the next year. This suggests a possible upside of 229.1% from the stock's current price. View analysts price targets for CURLF or view top-rated stocks among Wall Street analysts .

How have CURLF shares performed in 2023?

Curaleaf's stock was trading at $4.2973 at the beginning of the year. Since then, CURLF stock has decreased by 8.1% and is now trading at $3.95. View the best growth stocks for 2023 here .

Are investors shorting Curaleaf?

Curaleaf saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 5,209,000 shares, an increase of 19.3% from the October 15th total of 4,367,200 shares. Based on an average trading volume of 1,434,900 shares, the days-to-cover ratio is presently 3.6 days. View Curaleaf's Short Interest .

How were Curaleaf's earnings last quarter?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) released its quarterly earnings results on Thursday, November, 9th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by $0.03. The company earned $333.17 million during the quarter, compared to analysts' expectations of $341.07 million. Curaleaf had a negative net margin of 35.15% and a negative trailing twelve-month return on equity of 25.33%.

How do I buy shares of Curaleaf?

Shares of CURLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Curaleaf Stock Price, News & Analysis (OTCMKTS:CURLF)

$3.95

+0.09 (+2.33%)

(As of 12/5/2023 ET)

Compare

Today's Range: $3.74
▼
$3.96
50-Day Range: $2.61
▼
$4.57
52-Week Range: $2.19
▼
$7.88

Volume: 524,388 shs
Average Volume: 589,647 shs
Market Capitalization: $2.50 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $13.00

Stock Analysis Analyst Forecasts Chart Earnings Financials Headlines SEC Filings Short Interest

Curaleaf MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.63 Rating Score
Upside/Downside: 229.1% Upside
$13.00 Price Target
Short Interest: Healthy
0.80% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.30) to ($0.14) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.77 out of 5 stars

3.3

Analyst's Opinion

Consensus Rating
Curaleaf has received a consensus rating of Moderate Buy. The company's average rating score is 2.63, and is based on 6 buy ratings, 1 hold rating, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $13.00, Curaleaf has a forecasted upside of 229.1% from its current price of $3.95.
Amount of Analyst Coverage
Curaleaf has received no research coverage in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.80% of the outstanding shares of Curaleaf have been sold short.
Short Interest Ratio / Days to Cover
Curaleaf has a short interest ratio ("days to cover") of 7.4.
Change versus previous month
Short interest in Curaleaf has recently decreased by 2.98%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Curaleaf does not currently pay a dividend.
Dividend Growth
Curaleaf does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CURLF.

1.8

News and Social Media Coverage

News Sentiment
Curaleaf has a news sentiment score of 0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Consumer Discretionary companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Curaleaf this week, compared to 2 articles on an average week.
Search Interest
13 people have searched for CURLF on MarketBeat in the last 30 days. This is an increase of 225% compared to the previous 30 days.
MarketBeat Follows
Only 4 people have added Curaleaf to their MarketBeat watchlist in the last 30 days. This is a decrease of -43% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Curaleaf insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.04% of the stock of Curaleaf is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Curaleaf are expected to grow in the coming year, from ($0.30) to ($0.14) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Curaleaf is -5.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Curaleaf is -5.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Curaleaf has a P/B Ratio of 1.91. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Curaleaf Stock (OTCMKTS:CURLF)

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through Domestic Operations and International Operations segments. The company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. In addition, it offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. Further, the company provides hemp-based CBD and cannabigerol products. The company was founded in 2010 and is headquartered in New York, New York.

CURLF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CURLF Stock News Headlines

December 1, 2023 | finance.yahoo.com

Curaleaf Opens Second Dispensary in Sarasota, FL

November 27, 2023 | americanbankingnews.com

Critical Contrast: biote (NASDAQ:BTMD) vs. Curaleaf (OTCMKTS:CURLF)

December 6, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

November 20, 2023 | benzinga.com

Viridian Chart Of The Week: Finding The Right Balance Between Cheapness And Safety In Cannabis Stocks

November 10, 2023 | msn.com

Analyst Weighs In On Cannabis Giant Curaleaf's Q3 Results

November 10, 2023 | proactiveinvestors.com

Curaleaf 3Q earnings miss estimates; management bullish on market share gain opportunities

November 10, 2023 | finanznachrichten.de

Curaleaf Holdings, Inc.: Curaleaf Reports Third Quarter 2023 Results

November 9, 2023 | msn.com

Curaleaf Holdings Reports Q3 2023 Cannabis Revenue Of $333M, 23% EBITDA Margin

December 6, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

November 9, 2023 | finance.yahoo.com

Curaleaf Reports Third Quarter 2023 Results

November 8, 2023 | msn.com

Curaleaf product recalled due to possible fungal contamination

November 8, 2023 | proactiveinvestors.com

Curaleaf analysts eye gross margin, free cash flow in 3Q results

October 24, 2023 | proactiveinvestors.com

Curaleaf confirms layoffs ahead of potential TSX uplisting

October 10, 2023 | finance.yahoo.com

Curaleaf to Report Third Quarter 2023 Financial and Operational Results

October 10, 2023 | marketwatch.com

Curaleaf Applies to List Shares in Canada

October 10, 2023 | benzinga.com

Curaleaf Wants To Uplist To Toronto Stock Exchange, Applies Its Subordinate Voting Shares

October 10, 2023 | finance.yahoo.com

Curaleaf Applies to List Subordinate Voting Shares on the Toronto Stock Exchange

October 5, 2023 | msn.com

EXCLUSIVE: Curaleaf's Boris Jordan Puts Premium On Cannabis Quality, Says 'We Want To Be The Best'

October 3, 2023 | finance.yahoo.com

Curaleaf Announces Closing of C$16 Million Underwritten Offering of Subordinate Voting Shares

September 29, 2023 | ca.investing.com

Curaleaf plans TSX listing and capital raise amidst favorable cannabis legislation

September 28, 2023 | wsj.com

Curaleaf Founder Bullish on Marijuana-Banking Bill

September 28, 2023 | benzinga.com

EXCLUSIVE: Europe Is The Biggest Opportunity For Growth In The Cannabis Sector,' Curaleaf's Boris Jordan Tells Benzinga Cannabis Capital Conference

September 28, 2023 | markets.businessinsider.com

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (OtherSNYNF), Biophytis (BPTS) and Curaleaf Holdings (OtherCURLF)

September 28, 2023 | benzinga.com

Curaleaf Ready To Raise CA$16.2M With Securities Offering

September 28, 2023 | finance.yahoo.com

Curaleaf Announces C$16 Million Underwritten Offering of Subordinate Voting Shares

September 26, 2023 | msn.com

Curaleaf Executive Chairman: I think we're gonna get a positive bipartisan vote from the Senate

September 21, 2023 | markets.businessinsider.com

MSO Financial Health: Debt Restructuring Vs. Equity Raises – Analyst Digs Into Spreadsheets

See More Headlines

Receive CURLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Curaleaf and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/09/2023
Today: 12/06/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Medicinals & botanicals
Sub-Industry: N/A
Sector: Consumer Discretionary
Current Symbol: OTCMKTS:CURLF
CUSIP: N/A
CIK: 1756770
Web: www.curaleaf.com
Phone: 781-451-0351
Fax: N/A
Employees: 5,931
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $13.00
High Stock Price Target: $32.25
Low Stock Price Target: $4.25
Potential Upside/Downside: +229.1%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.63
Research Coverage: 8 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.66)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-370,100,000.00
Net Margins: -35.15%
Pretax Margin: -25.24%
Return on Equity: -25.33%
Return on Assets: -9.35%

Debt

Debt-to-Equity Ratio: 0.73
Current Ratio: 0.87
Quick Ratio: 0.47

Sales & Book Value

Annual Sales: $1.34 billion
Price / Sales: 1.87
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.07 per share
Price / Book: 1.91

Miscellaneous

Outstanding Shares: 634,000,000
Free Float: N/A
Market Cap: $2.50 billion
Optionable: Not Optionable
Beta: 1.83

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. Boris Alexis Jordan (Age 57)
Executive Chairman
Comp: $1.75M
Mr. Matthew S. Darin
Chief Executive Officer
Mr. Joseph F. Lusardi (Age 49)
Executive Vice-Chairman
Comp: $657.7k
Mr. Edward Kremer (Age 51)
Chief Financial Officer
Comp: $461.74k
Mr. Joe Holland
Executive Vice President of Operations
Mr. Camilo Russi Lyon
Chief Investment Officer
Mr. Jakob Feinstein
Manager of Investor Relations
Mr. Peter Laurence Clateman J.D. (Age 55)
Chief Legal Officer
Mr. James S. Shorris (Age 61)
Chief Compliance Officer
Ms. Tracy Brady
Senior Vice President of Corporate Communications

Key Competitors

View All Competitors

CURLF Stock Analysis - Frequently Asked Questions

Should I buy or sell Curaleaf stock right now?: 8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Curaleaf in the last year. There are currently 1 sell rating, 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CURLF shares.
View CURLF analyst ratings or view top-rated stocks.
What is Curaleaf's stock price target for 2024?: 8 Wall Street analysts have issued 12 month price targets for Curaleaf's stock. Their CURLF share price targets range from $4.25 to $32.25. On average, they predict the company's share price to reach $13.00 in the next year. This suggests a possible upside of 229.1% from the stock's current price.
View analysts price targets for CURLF or view top-rated stocks among Wall Street analysts.
How have CURLF shares performed in 2023?: Curaleaf's stock was trading at $4.2973 at the beginning of the year. Since then, CURLF stock has decreased by 8.1% and is now trading at $3.95.
View the best growth stocks for 2023 here.
Are investors shorting Curaleaf?: Curaleaf saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 5,209,000 shares, an increase of 19.3% from the October 15th total of 4,367,200 shares. Based on an average trading volume of 1,434,900 shares, the days-to-cover ratio is presently 3.6 days.
View Curaleaf's Short Interest.

How were Curaleaf's earnings last quarter?: Curaleaf Holdings, Inc. (OTCMKTS:CURLF) released its quarterly earnings results on Thursday, November, 9th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by $0.03. The company earned $333.17 million during the quarter, compared to analysts' expectations of $341.07 million. Curaleaf had a negative net margin of 35.15% and a negative trailing twelve-month return on equity of 25.33%.
How do I buy shares of Curaleaf?: Shares of CURLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:CURLF) was last updated on 12/6/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial